Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Discriminating between essential thrombocythemia and masked polycythemia vera in JAK2 mutated patients.

American journal of hematology - 1 Jun 2014

Barbui Tiziano, Thiele Jürgen, Carobbio Alessandra, Guglielmelli Paola, Rambaldi Alessandro, Vannucchi Alessandro M, Tefferi Ayalew

Abstract excerpt

In patients not meeting the required hematocrit (HCT) or hemoglobin (Hb) thresholds according to BCSH and the WHO diagnostic criteria, the diagnosis of masked polycythemia vera (mPV) has been proposed. A comparison of HCT or Hb values with the expression of JAK2V617F, JAK2 exon 12, and CALR mutat...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diagnosis, Differential
Share to Hematocrit
Share to Hemoglobins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Janus Kinase 2

Share to Mutation

Share to Polycythemia Vera

Share to Sex Factors

Share to Thrombocythemia, Essential

Source

Identifiers

PMID: 24535932
DOI: 10.1002/ajh.23694

Genes

JAK2
CALR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24535932-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Discriminating between essential thrombocythemia and masked polycythemia vera in JAK2 mutated patients.PMID 24535932Read ↗

Masked polycythemia vera diagnosed according to WHO and BCSH classification.Semantic proximity Read ↗

Low-hemoglobin Polycythemia Vera: Diagnostic Criteria and Clinico-pathological CharacterizationSemantic proximity Read ↗

Masked polycythemia vera (mPV): results of an international study.Semantic proximity Read ↗

Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis.Semantic proximity Read ↗

Masked polycythaemia vera: presenting features, response to treatment and clinical outcomes.Semantic proximity Read ↗

Polycythemia vera: from new, modified diagnostic criteria to new therapeutic approaches.Semantic proximity Read ↗

European LeukemiaNet study on the reproducibility of bone marrow features in masked polycythemia vera and differentiation from essential thrombocythemia.Semantic proximity Read ↗

Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel.Semantic proximity Read ↗

Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemiaSemantic proximity Read ↗

Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.Semantic proximity Read ↗

The revised WHO diagnostic criteria for Ph-negative myeloproliferative diseases are not appropriate for the diagnostic screening of childhood polycythemia vera and essential thrombocythemiaSemantic proximity Read ↗

Clinical characteristics of Japanese patients with polycythemia vera: results of the JSH-MPN-R18 study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.